Back to Results
First PageMeta Content
Endocrinology / Diabetes management / Diabetes mellitus / Tolbutamide / Gestational diabetes / Hypoglycemia / Anti-diabetic medication / Insulin / Hyperglycemia / Diabetes / Endocrine system / Medicine


Ontario Public Drug Programs, Ministry of Health and Long-Term Care Notice from the Executive Officer: Blood Glucose Test Strip Reimbursement Policy The Executive Officer is introducing changes to the reimbursement of B
Add to Reading List

Document Date: 2013-07-08 15:36:12


Open Document

File Size: 37,62 KB

Share Result on Facebook

Company

Canadian Agency for Drugs / /

Event

Person Communication and Meetings / /

Facility

Ontario College of Pharmacists / /

IndustryTerm

diabetes therapy / online and paper claims / drug insurance / healthcare / insulin products / healthcare professional / healthcare providers / Diabetes Treatment / drug insurance plans / /

MedicalCondition

period Patients managing diabetes / acute illness / free diabetes MedsCheck / hyperglycemia / managing diabetes / diabetes / Patients managing diabetes / infection / hypoglycemia Patients managing diabetes / hypoglycemia / /

MedicalTreatment

self-management / /

Organization

Ontario College of Pharmacists / Technologies in Health / Canadian Agency for Drugs and Technologies / Canadian Diabetes Association / Ministry of Health / /

Position

Executive Officer / Governor / pharmacist / Glucose Test Strip Reimbursement Policy The Executive Officer / /

Product

pioglitazone / tolbutamide / glimepiride / chlorpropamide / glyburide / repaglinide / nateglinide / rosiglitazone / /

PublishedMedium

the Canadian Journal / /

URL

www.ontario.ca/medscheck / www.ontario.ca/diabetes / www.health.gov.on.ca/diabetesteststrips / /

SocialTag